Prediction of pre-eclampsia and eclampsia complications using PIERS

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Risk Prediction

Background:

• Preeclampsia and eclampsia contribute to significant global maternal mortality.
• Effective risk assessment tools are crucial for managing these conditions.
• Adverse feto-maternal outcomes necessitate improved diagnostic and prognostic strategies.

Purpose of the Study:

• To evaluate the utility of the Preeclampsia Integrated Estimate of Risk Score (PIERS) in assessing complications of preeclampsia and eclampsia.
• To determine the association between maternal health conditions and adverse feto-maternal outcomes.
• To support the incorporation of the PIERS score into standard obstetric care.

Main Methods:

• Retrospective analysis of 60 patients diagnosed with preeclampsia or eclampsia.
• Categorization into two groups: 14 with Adverse Maternal Outcome (AMO) and 46 without AMO.
• Evaluation using laboratory investigations and the PIERS score for Adverse Feto-Maternal Outcomes (AFMO).

Main Results:

• Maternal health conditions significantly impact fetal outcomes.
• A notable percentage of newborns required intensive care and exhibited distress post-delivery.
• The PIERS score demonstrated potential in identifying patients at risk for adverse outcomes.

Conclusions:

• The PIERS score is a valuable tool for assessing preeclampsia and eclampsia complications.
• Integrating the PIERS score into obstetric practice can improve patient management and outcomes.
• Early identification and management of high-risk pregnancies are essential for reducing maternal and fetal morbidity.